Polycythemia vera
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Polycythemia vera is a condition characterised by an increased number of red blood cells in the bloodstream. Affected individuals may also have excess white blood cells and blood clotting cells called platelets. These extra cells and platelets cause the blood to be thicker than normal. As a result, abnormal blood clots are more likely to form and block the flow of blood through arteries and veins. Individuals with polycythemia vera have an increased risk of deep vein thrombosis (DVT), a type of blood clot that occurs in the deep veins of the arms or legs. If a DVT travels through the bloodstream and lodges in the lungs, it can cause a life-threatening clot known as a pulmonary embolism (PE). Affected individuals also have an increased risk of heart attack and stroke caused by blood clots in the heart and brain.
Video picks for Genetic conditionsVideo library
Description
Polycythemia vera is a condition characterised by an increased number of red blood cells in the bloodstream. Affected individuals may also have excess white blood cells and blood clotting cells called platelets. These extra cells and platelets cause the blood to be thicker than normal. As a result, abnormal blood clots are more likely to form and block the flow of blood through arteries and veins. Individuals with polycythemia vera have an increased risk of deep vein thrombosis (DVT), a type of blood clot that occurs in the deep veins of the arms or legs. If a DVT travels through the bloodstream and lodges in the lungs, it can cause a life-threatening clot known as a pulmonary embolism (PE). Affected individuals also have an increased risk of heart attack and stroke caused by blood clots in the heart and brain.
Polycythemia vera typically develops in adulthood, around age 60, although in rare cases it occurs in children and young adults. This condition may not cause any symptoms in its early stages. Some people with polycythemia vera experience headaches, dizziness, ringing in the ears (tinnitus), impaired vision, or itchy skin. Affected individuals frequently have reddened skin because of the extra red blood cells. Other complications of polycythemia vera include an enlarged spleen (splenomegaly), stomach ulcers, gout (a form of arthritis caused by a buildup of uric acid in the joints), heart disease, and cancer of blood-forming cells (leukemia).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant; Not inherited. More than one pattern can apply in different cases.
Related genes
Other names
Osler-Vaquez disease
Polycythemia ruba vera
Primary polycythemia
PRV
PV
Patient picks for Genetic conditions

Allergies, blood and immune system
Polycythaemia rubra vera
Polycythaemia rubra vera (PRV) is a myeloproliferative disorder, which means the bone marrow makes too many blood cells. It is also sometimes just called polycythaemia (PV). There is an abnormally high number of red blood cells in your blood. You may also have an abnormally high number of platelets and white blood cells.
by Dr Hayley Willacy, FRCGP

Diet and nutrition
Does aloe vera juice really help with gut health?
Numerous claims about the health benefits of drinking aloe vera juice have been made on social media. It can supposedly treat wounds, revitalise skin, and improve gut health. But how trustworthy is this advice?
by Emily Jane Bashforth

Skin, nail and hair health
Is aloe vera good for your skin?
Aloe vera has long been a popular wellness choice for its calming and moisturising effects. Whether harvested directly from the plant itself or bought as a ready-made product, it's a top contender for promoting healthy skin. But what exactly makes this fleshy green succulent so good for our complexion?
by Victoria Raw

Medicine
Verapamil - a calcium-channel blocker
You can take verapamil either before or after meals. Do not drink grapefruit juice whilst you are on verapamil. The most common side-effect of treatment is constipation.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Polycythaemia rubra vera
Polycythaemia rubra vera (PRV) is a myeloproliferative disorder, which means the bone marrow makes too many blood cells. It is also sometimes just called polycythaemia (PV). There is an abnormally high number of red blood cells in your blood. You may also have an abnormally high number of platelets and white blood cells. Polycythaemia rubra vera.

Patient information leaflet
How to prevent DVT when travelling
This leaflet advises on how to reduce the risk of a deep vein thrombosis occurring during a long journey. Another leaflet discusses deep vein thrombosis in more detail. If you need more detaile... Obesity. Obesity and weight loss Cancer. Some blood clotting disorders (for example, polycythaemia Polycythaemia rubra vera or thrombophilia.

Patient information leaflet
Transient ischaemic attack
Cross-section diagram showing ... These include: Blood clotting problems. Tiny bleeds into the brain. Blood disorders such as polycythaemia Polycythaemia rubra vera and sickle cell anaemia Sickle cell disease where the blood is very thick. Spasm of a small artery in the brain. A blood clot from the veins of the leg (a deep vein thrombosis Deep.

Patient information leaflet
Blood tests to detect inflammation
In this way they are used as markers of ... Note : the information below is a general guide only. The arrangements, and the way the inflammation blood test is performed, may vary between different hospitals. Some conditions lower the ESR - for example: Heart failure Heart failure. Polycythaemia. Polycythaemia rubra vera Sickle-cell anaemia. Sickle.

Patient information leaflet
Myelofibrosis
Myelofibrosis is a condition affecting the bone marrow and its blood cell production. Secondary myelofibrosis can be caused by other conditions such as essential thrombocythaemia or polycythaemia rubra vera Polycythaemia rubra vera. Already having another blood disorder, such as essential thrombocythaemia or polycythaemia rubra vera. Dr Sarah.

Patient information leaflet
Mouth ulcers
Mouth ulcers are common, painful sores inside the mouth that can make eating and drinking uncomfortable. Mouth ulcers are painful sores that can occur anywhere inside the mouth. This leaflet is about the most common type of mouth ulcers, which are aphthous mouth ulcers. At least 1 in 4 people develop aphthous mouth ulcers at some stage in their.
Further reading and references
- Polycythemia vera; MedlinePlus, National Library of Medicine.
- Cario H, McMullin MF, Pahl HL. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol. 2009 Aug;88(8):713-9. doi: 10.1007/s00277-009-0758-y. Epub 2009 May 26.
- Delhommeau F, Jeziorowska D, Marzac C, Casadevall N. Molecular aspects of myeloproliferative neoplasms. Int J Hematol. 2010 Mar;91(2):165-73. doi: 10.1007/s12185-010-0530-z. Epub 2010 Feb 27.
- Gangat N, Strand J, Lasho TL, Finke CM, Knudson RA, Pardanani A, Li CY, Ketterling RP, Tefferi A. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates. Eur J Haematol. 2008 Mar;80(3):197-200. doi: 10.1111/j.1600-0609.2007.01003.x. Epub 2007 Dec 7.
- Landolfi R, Nicolazzi MA, Porfidia A, Di Gennaro L. Polycythemia vera. Intern Emerg Med. 2010 Oct;5(5):375-84. doi: 10.1007/s11739-010-0369-6. Epub 2010 Mar 16.
- Mehta J, Wang H, Iqbal SU, Mesa R. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 2014 Mar;55(3):595-600. doi: 10.3109/10428194.2013.813500. Epub 2013 Jul 29.
- Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia. 2010 Jun;24(6):1128-38. doi: 10.1038/leu.2010.69. Epub 2010 Apr 29.
- Thiele J, Kvasnicka HM. The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Curr Hematol Malig Rep. 2009 Jan;4(1):33-40. doi: 10.1007/s11899-009-0005-6.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

